Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 2
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Endocrine Complications of Cystic Fibrosis.
Kelly A, Marks BE, Stalvey MS. Kelly A, et al. Clin Chest Med. 2022 Dec;43(4):773-789. doi: 10.1016/j.ccm.2022.06.013. Clin Chest Med. 2022. PMID: 36344080 Free PMC article. Review.
Case Report: Insulin hypersensitivity in youth with type 1 diabetes.
Alkhatib EH, Grundman JB, Adamusiak AM, Bellin MD, Brooks JP, Buckley KS, Janssen EM, Kitcharoensakkul M, McNerney KP, Pfeifer TL, Polk BI, Marks BE. Alkhatib EH, et al. Front Endocrinol (Lausanne). 2023 Oct 20;14:1226231. doi: 10.3389/fendo.2023.1226231. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37929017 Free PMC article. Review.
Endpoints for clinical trials in type 1 diabetes drug development.
Galderisi A, Marks BE, DiMeglio LA, de Beaufort C. Galderisi A, et al. Lancet Diabetes Endocrinol. 2024 May;12(5):297-299. doi: 10.1016/S2213-8587(24)00097-4. Lancet Diabetes Endocrinol. 2024. PMID: 38663944 No abstract available.
ROUTE-T1D: A behavioral intervention to promote optimal continuous glucose monitor use among racially minoritized youth with type 1 diabetes: Design and development.
Straton E, Bryant BL, Kang L, Wang C, Barber J, Perkins A, Gallant L, Marks B, Agarwal S, Majidi S, Monaghan M, Streisand R. Straton E, et al. Contemp Clin Trials. 2024 May;140:107493. doi: 10.1016/j.cct.2024.107493. Epub 2024 Mar 7. Contemp Clin Trials. 2024. PMID: 38460913 Clinical Trial.
The Coronavirus Disease 2019 Pandemic is Associated with a Substantial Rise in Frequency and Severity of Presentation of Youth-Onset Type 2 Diabetes.
Magge SN, Wolf RM, Pyle L, Brown EA, Benavides VC, Bianco ME, Chao LC, Cymbaluk A, Balikcioglu PG, Halpin K, Hsia DS, Huerta-Saenz L, Kim JJ, Kumar S, Levitt Katz LE, Marks BE, Neyman A, O'Sullivan KL, Pillai SS, Shah AS, Shoemaker AH, Siddiqui JAW, Srinivasan S, Thomas IH, Tryggestad JB, Yousif MF, Kelsey MM; COVID-19 and Type 2 Diabetes Consortium. Magge SN, et al. J Pediatr. 2022 Dec;251:51-59.e2. doi: 10.1016/j.jpeds.2022.08.010. Epub 2022 Aug 17. J Pediatr. 2022. PMID: 35985535 Free PMC article.
Applying the use of shared medical appointments (SMAs) to improve continuous glucose monitor (CGM) use, glycemic control, and quality of life in marginalized youth with type 1 diabetes: Study protocol for a pilot prospective cohort study.
Grundman JB, Majidi S, Perkins A, Streisand R, Monaghan M, Marks BE. Grundman JB, et al. Contemp Clin Trials Commun. 2023 Jan 16;32:101067. doi: 10.1016/j.conctc.2023.101067. eCollection 2023 Apr. Contemp Clin Trials Commun. 2023. PMID: 36698741 Free PMC article.